Biotechnology

Sai Life Sciences opens new Discovery Biology facility at its integrated R&D campus in Hyderabad, India

HYDERABAD, India, Aug. 18, 2021 /PRNewswire/ -- Sai Life Sciences, a leading globalContract Research, Development & Manufacturing Organization (CRO-CDMO), today announced the opening of a newbiology facility

2021-08-18 20:20 4312

HistoIndex's Stain-free AI-based Digital Pathology Incorporated as Secondary and Exploratory Efficacy Endpoints in Sagimet's NASH FASCINATE-2 Phase 2b Clinical Trial

SINGAPORE, Aug. 18, 2021 /PRNewswire/ -- HistoIndex , a global leading artificial intelligence (AI) digital pathology provider, has announced an agreement with clinical-stage biotechnology company Sagimet Biosciences. HistoIndex's integrated suite of stain-free imagi...

2021-08-18 18:00 2216

PharmAbcine to Participate in Biotechgate Digital Partnering

DAEJEON, South Korea, Aug. 17, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next generation antibody therapeutics, announced today that the Company will participate in Biotechgate Digital Partnering taking place virtuall...

2021-08-17 20:00 1782

MediTrust Health Raises Over RMB2 Billion in Series C Financing Successfully: ESG Drives Value Creation

HONG KONG, Aug. 17, 2021 /PRNewswire/ -- Shanghai MediTrust Health Technology Co., Ltd. (hereinafter referred to as "MediTrust"), a leading innovative healthcare services platform inChina, announced a successful capital raising of overRMB2 billion (approximately US$308 million) in a Series C fina...

2021-08-17 19:47 2709

Innoforce Pharmaceuticals Opens Analytical Development and Process Development Facility in Hangzhou, China

HANGZHOU, China and ROCKVILLE, Md., Aug. 17, 2021 /PRNewswire/ -- Innoforce Pharmaceuticals ("Innoforce"), a biopharmaceutical innovation and partnership company, today announces that it has opened a new Advanced Cell and Gene Therapy Development Facility inHangzhou, China. Analytical development...

2021-08-17 19:00 2878

First Edition of World Conference on Early Detection of Cancer Set to Start in November in Hainan, China

GUANGZHOU and HAIKOU, China, Aug. 16, 2021 /PRNewswire/ -- Early detection and diagnosis of cancer is an essential enabler of curative treatment and an effective solution to boost the survival rates of cancer patients worldwide. In an effort to lead the way in innovative research and strategies f...

2021-08-16 22:13 2401

Ascletis' Partner Sagimet Dosed First Patient in FASCINATE-2 Phase IIb Trial in NASH Patients with Moderate to Advanced Fibrosis

HANGZHOU and SHAOXING, China, Aug. 16, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) today announces that its partner Sagimet Biosciences dosed the first patient in its FASCINATE-2 Phase IIb clinical trial for non-alcoholic steatohepatitis (NASH). FASCINATE-2 is a randomized, double-blin...

2021-08-16 21:30 4367

Gracell Biotechnologies Signs Exclusive License Agreement with FutureGen Biopharm to Develop Engineered Immune Cell Therapies Targeting Claudin 18.2 in Solid Tumors

SUZHOU and SHANGHAI, China, and PALO ALTO, Calif., Aug. 16, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today ...

2021-08-16 20:00 3196

BioAgilytix to Purchase Australia-based 360biolabs®

Highly complementary transaction will strengthen company's ability to support bioanalytical services across all stages, development capabilities and geographies DURHAM, N.C., Aug. 16, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused ...

2021-08-16 18:00 4354

Senhwa Completes Enrollment of a Phase 2 Investigator Initiated Trial of Silmitasertib as Novel Oral Drug for COVID-19

TAIPEI and SAN DIEGO, Aug. 16, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focused on human efficacy and innovation of first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today announced that its novel oral drug, Silmita...

2021-08-16 15:29 2173

Qiming's Portfolio Company Sino Biological Lists on Shenzhen's ChiNext Market

SHANGHAI, Aug. 16, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Sino Biological (SZSE: 301047) onAugust 16th listed on Shenzhen's ChiNext Market. The issue price isCNY 292.92 per share. The stock opened at CNY 599.9, up 104.8%, representing a market cap of CNY 40.79 billion. Q...

2021-08-16 14:14 3683

Sino Biological Announces Successful Closing of 4.98 Billion RMB Public Offering and Listing on the Shenzhen ChiNext Stock Exchange

BEIJING, Aug. 16, 2021 /PRNewswire/ -- Sino Biological, Inc. ("Sino Biological" or the "Company"), a biotechnology company which provides biological research reagents and related technical contract research services, announced a successful listing on the Shenzhen Stock Exchange subsidiary ChiNext...

2021-08-16 13:12 6278

GeneQuantum announces a key leadership appointment

SUZHOU, China, Aug. 15, 2021 /PRNewswire/ -- GeneQuantum Healthcare, an industry leading biopharmacetucial company dedicated to next generation bioconjugate drugs through innovative intelligent ligase-dependent conjugation (iLDC) technology platform, announced a key appointment to further strengt...

2021-08-16 10:00 1744

InxMed's IN10018 Receives U.S. FDA Fast Track Designation for the Treatment of Platinum-resistant Ovarian Cancer

NANJING, China, Aug. 15, 2021 /PRNewswire/ -- InxMed (Nanjing) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced today the U.S. Food and Drug Administration (FDA) has granted Fas...

2021-08-16 09:31 1962

Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and India

SHANGHAI, Aug. 15, 2021 /PRNewswire/ -- Arctic Vision, a China-based biotech company focused on innovative ophthalmic therapies, announced today the entering of an amendment to the exclusive license agreement with its partner Clearside Biomedical, Inc. (Nasdaq: CLSD) ("Clearside"), to expand the ...

2021-08-16 08:00 8342

TurtleTree and Solar Biotech enter strategic partnership

WOODLAND, Calif., Aug. 13, 2021 /PRNewswire/ -- Solar Biotech, led by industrial biotech expertAlex Berlin, has become a significant piece of the puzzle for sustainable food tech companies taking products to market. TurtleTree knew from the beginning that one of the biggest challenges for food t...

2021-08-13 21:00 5142

A3P Biomedical AB: Fast track publication of the STHLM3 MRI trial in The Lancet Oncology

STOCKHOLM, Aug. 13, 2021 /PRNewswire/ -- A3P Biomedical AB today announced that the publication of the STHLM3 MRI trial including 12,750 men has been fast tracked and is now published in the  renowned peer-reviewed scientific publication The Lancet Oncology1. Results from the STHLM3 MRI trial, p...

2021-08-13 12:22 1950

TOT BIOPHARM Anounces 2021 Interim Results

Revenue Surges 78% to RMB23.13 million CDMO Business Achieves Leapfrog Breakthrough Two Products Approved for Launch Smooth Progress of Various Core Anti-tumor Drugs Clinical Trials To Allocate Resources to Boost Innovative ADC Drugs HONG KONG and SUZHOU, China, Aug. 13, 2021 /PRNewswire/ -- TOT B...

2021-08-13 10:59 20673

WuXi AppTec Reports Strong 2021 Interim Results

* Revenue Up 45.7% Year-Over-Year to RMB10,537 Million * Net Profit Attributable to Owners of the Company Up 55.8% Year-Over-Year to RMB2,675 Million * Diluted EPS Up 46.8% Year-Over-Year to RMB0.91 * Adjusted Non-IFRS[1] Net Profit Attributable to Owners of the Company Up 67.8% Year-Over-...

2021-08-12 17:52 3928

NUHS Embarks on Holomedicine Research in Singapore, Using Mixed Reality Technology to Enhance Diagnosis, Education and Patient Care

SINGAPORE, Aug. 12, 2021 /PRNewswire/ -- To be able to literally "see inside" a patient's skull and identify the location of the tumour deep in the brain, right on the operating table, may no longer be science fiction with the help of a Mixed Reality (MR) headset.

2021-08-12 15:00 2532
1 ... 331332333334335336337 ... 348